Operating Segments

6 Months Ended

Jun. 30, 2020

Segment Reporting [Abstract]

Operating Segments

Note 9. Operating Segments

The Company maintains two active operating segments: Specialized BioTherapeutics and Public Health Solutions. Each segment includes an element of overhead costs specifically associated with its operations, with its corporate shared services group responsible for support functions generic to both operating segments.

	Three Months Ended June 30,
	2020			2019
Revenues
Public Health Solutions	$	468,009		$	1,095,865
Specialized BioTherapeutics		37,279			449,099
Total	$	505,288		$	1,544,964
Income/(Loss) from Operations
Public Health Solutions	$	(50,737	)	$	204,121
Specialized BioTherapeutics		(1,808,652	)		(1,462,334	)
Corporate		(954,483	)		(905,678	)
Total	$	(2,813,872	)	$	(2,164,891	)
Amortization and Depreciation Expense
Public Health Solutions	$	7,318		$	4,316
Specialized BioTherapeutics		3,167			4,168
Corporate		7,317			4,448
Total	$	17,802		$	12,932
Other Income, Net
Specialized BioTherapeutics	$	35,091		$	(2,339	)
Corporate		2,018			43,709
Total	$	37,109		$	41,370
Share-Based Compensation
Public Health Solutions	$	8,377		$	8,072
Specialized BioTherapeutics		18,962			19,094
Corporate		53,664			45,726
Total	$	81,003		$	72,892

	Six Months Ended June 30,
	2020			2019
Revenues
Public Health Solutions	$	1,376,818		$	1,776,218
Specialized BioTherapeutics		53,024			913,534
Total	$	1,429,842		$	2,689,752
Income/(Loss) from Operations
Public Health Solutions	$	(209,239	)	$	195,110
Specialized BioTherapeutics		(9,166,503	)		(2,798,891	)
Corporate		(1,911,919	)		(1,861,173	)
Total	$	(11,287,661	)	$	(4,464,954	)
Amortization and Depreciation Expense
Public Health Solutions	$	14,621		$	8,718
Specialized BioTherapeutics		6,237			8,845
Corporate		14,590			5,429
Total	$	35,448		$	22,992
Other Income, Net
Specialized BioTherapeutics	$	68,706		$	2,670
Corporate		23,965			88,460
Total	$	92,671		$	91,130
Share-Based Compensation
Public Health Solutions	$	17,842		$	13,268
Specialized BioTherapeutics		44,251			40,002
Corporate		82,601			99,195
Total	$	144,694		$	152,465

	As of		As of
	June 30,		December 31,
	2020		2019
Identifiable Assets
Public Health Solutions	$	273,943	$	1,018,673
Specialized BioTherapeutics		86,639		41,705
Corporate		11,900,092		6,714,982
Total	$	12,260,674	$	7,775,360